Advanced search
Publication Cover
Acta Cardiologica Volume 70, 2015 - Issue 2
Submit an article Journal homepage
32
Views
14
CrossRef citations to date
0
Altmetric
Articles

Systemic lupus erythematosus: the influence of disease-related and classical risk factors on intima media thickness and prevalence of atherosclerotic plaques - a preliminary report. Beneficial effect of immunosuppressive treatment on carotid intima media thickness

Bart³omiej KisielDept. of Internal Diseases and Rheumatology, Military Institute of Medicine, Warszawa, PolandCorrespondence[email protected]
, Md, Phd;,
Robert KruszewskiDept. of Internal Diseases and Rheumatology, Military Institute of Medicine, Warszawa, Poland
, Md;,
Aleksandra JuszkiewiczDept. of Internal Diseases and Rheumatology, Military Institute of Medicine, Warszawa, Poland
, Md, Phd;,
Anna RaczkiewiczDept. of Internal Diseases and Rheumatology, Military Institute of Medicine, Warszawa, Poland
, Md, Phd,
Artur BachtaDept. of Internal Diseases and Rheumatology, Military Institute of Medicine, Warszawa, Poland
, Md, Phd;,
Krzysztof K£osDept. of Infectious Diseases and Allergology, Military Institute of Medicine, Warszawa, Poland
, Md, Phd;,
Krzysztof DudaDept. of Radiology, Military Institute of Medicine, Warszawa, Poland
, Md;,
Marek SaracynDept. of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warszawa, Poland
, Md, Phd;,
Konrad SzymañskiDept. of Medical Genetics, Warsaw Medical University, Warszawa, Poland
, Ms;,
Agnieszka M£oniak-cieŒlaConnective Tissue Disease Dept., Institute of Rheumatology, Warszawa, Poland.
, Md;,
Agnieszka Grabowska-JodkowskaConnective Tissue Disease Dept., Institute of Rheumatology, Warszawa, Poland.
, Md;,
Marzena OlesiñskaConnective Tissue Disease Dept., Institute of Rheumatology, Warszawa, Poland.
, Md, Phd;,
Romana Bogus£awska-WaleckaDept. of Radiology, Military Institute of Medicine, Warszawa, Poland
, Md, Phd;,
Stanis ³Aw NiemczykDept. of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warszawa, Poland
, Md, Phd;,
Rafa ³ P£OskiDept. of Medical Genetics, Warsaw Medical University, Warszawa, Poland
, Md, Phd; &
Witold T£UstochowiczDept. of Internal Diseases and Rheumatology, Military Institute of Medicine, Warszawa, Poland
, Md, Phd show all
Pages 169-175 | Received 13 Oct 2014, Accepted 22 Dec 2014, Published online: 23 May 2017

  • Ward MM. Premature morbidity form cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 338–46.
  • Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol 1987; 14:223–6.
  • Manzi 5, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, Kuller LH. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 51–60.
  • Roman MJ, Shanker BA, Davis A, Lockshin LD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE. Prevalence of correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349:2399–406.
  • Petri M, Perez-Gutthann 5, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93: 513–9.
  • Esdaile JM, Abrahamowicz M, Grodzicky, TY, Li Y, Panaritis C, du Berger R, Cote R, Grover SA, Fortin PR, Clarke AE, Senecal JL. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44:2331–7.
  • Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115:459–67.
  • Tyrrell PN, Beyene J, Feldman BM, McCrindle BW, Silverman ED, Bradley TJ. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arteriosder Thromb Vasc Biol 2010; 30: 1014–26.
  • Hassan AA, Habib HM, Eissa AA. Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study. Int J Rheum Dis 2013; 16:319–24.
  • Kiani AN, Post WS, Magder LS, Petri M. Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus. Rheumatology (Oxford) 2011; 50: 2071–9.
  • Sazliyana 5, Mohd Shahrir MS, Norella Kong CT, Tan HJ, Hamidon BB, Azmi MT. Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients. Lupus 2011; 20:1260–6.
  • Oryoji K, Kiyohara C, Horiuchi T, Tsukamoto H, Niiro H, Shimodo T, Akashi K, Yanase T. Reduced carotid intima-media thickness in systemic lupus erythematosus patients treated with cyclosporine A. Mod Rheumatol 2014; 24: 86–92.
  • Liang HR, Socher SA, Larson MA, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107–18.
  • Gladman DD, Urowitz MB, Goldsmith CH, Fortin P. Ginzler E, Gordon C, Hanly JG, Isenberg DA, Kalunian K, Nived 0, Petri M, Sanchez-Guerrero J, Snaith M, Sturfelt G.The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809–13.
  • D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117:743–53.
  • Touboul PJ, Hennerici MG, Meairs 5, Adams H, Amarenco P. Bornstein N, Csiba L, Desvarieux M, Ebrahim 5, Fatar M, Hernandez Hernandez R, Jaff M, Kownator 5, Prati P. RundekT, Sitzer M, Schminke U, TardifJC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M. Mannheim carotid intima media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the r and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23: 75–80.
  • Maksimowicz-McKinnon K, Magder LS, Petri M. Predictors of carotid atherosclerosis in systemic lupus erythematosus. J Rheumatol 2006; 33:2458–63.
  • Ahmad Y, Shelmerdine J, Bodill H, Lunt M, Pattrick MG, Teh LS, Bernstein RM, Walker MG, Bruce IN. Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. Rheumatology (Oxford) 2007; 46:983–8.
  • Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio 5, Linton MF, Raggi P. Stein CM. Premature coronary artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2407–15.
  • Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 2000; 9: 170–5.
  • Burgos PI, Vila LM, Reveille JD, Alarcón GS. Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX). Lupus 2009; 18:1303–8.
  • Barna be C, Martin BJ, Ghali WA. Systematic review and meta-analysis: anti-tumour necrosis factor a therapy and cardiovascular events in rheumatoid events. Arthritis Care Res 2011; 63:522–9.
  • Dixon WG, Watson KD, Lunt M, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007; 56: 2905–12.
  • Greenberg JD, KremerJM, Curtis JR Hochberg MC, Reed G, Tsao P, Farkouh ME, Nasir A, Setoguchi S, Solomon DH; CORRONA Investigators.Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis 2011; 70:576–82.
  • Westlake SL, Colebatch AN, Baird J, Kiely P. Quinn M, Choy E, Ostor AJ, Edwards CJ. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) 2010; 49: 295–307.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.